IPHARMA, the accredited Common Use Center (CUC) for "Biomedical Services" of Technopark "Skolkovo", is a fast-growing innovative CRO in Russia and EAEU.
Our pipeline consists of over 60 clinical trials in endocrinology, oncology, dermatology, virology, pulmonology, neurology, transplantology, etc. We provide agile clinical services in both early-phase and registration trials, as well as medical, regulatory, and PV expertise to ensure optimal timeline for your drug development.
According to Association of Clinical Trials Organizations, IPHARMA has been ranked as a market leader of Russian innovative drugs (ACTO Analytical report #8 for 2013, #10 for 2014, #12 for 2015 and #14 for 2016).
Our contract research organization is a trusted partner and ideal platform for the clinical development of new drugs.
Advantages of working with IPHARMA:
1. Leading positions on the market of Russian innovative drugs according to ACTO analytical report for 2013 - 2016.
2. Opportunities for drug localization, investments, and market access.
3.Full cycle of drug development: formulation, batches, QC, preclinical, clinical.
4. Medical and PV expertise with access to top scientists and KOLs.
5. Quality management systems and experienced staff.